In CRC patients tumor samples, high expression and nuclear localization of YAP correlated strongly with disease evolution and bad prognosis [33, 51], or with resistance to treatments such as 5FU or cetuximab [22, 27, 58]. The gene discussed is YAP1; the disease is colorectal carcinoma.